Bioequivalence Test of "Dong-a Bepotastine Besilate Tab" and "Twolion Tab"
Status:
Completed
Trial end date:
2019-05-28
Target enrollment:
Participant gender:
Summary
An Open-Label, Randomized, 2-sequence, 2-period, Fasted Condition, Single-dose, Per Oral,
Cross-over Study to Evaluate the Bioequivalence of "Dong-a Bepotastine Besilate Tab"
(Bepotastine Besilate 10mg) and "Twolion Tab" (Bepotastine Besilate 10mg) in Healthy
Volunteers